Validation of a neutralizing antibody (NAb) assay with an extended reportable range for entranacogene dezaparvovec, an adeno-associated virus serotype 5 (AAV5)-based gene therapy for adult hemophilia B (ISTH 2024)
International Society on Thrombosis and Haemostasis